Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Castle Biosciences, Inc. (CSTL) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$86.19M
Net Income	$4.52M
Cost of Goods Sold	$17.63M
Gross Profit	$68.56M
Operating Expenses	$90.44M
Operating Income	$-4.25M
Non-Operating Income/Expense	$4.11M
Pre-Tax Income	$-0.14M
Normalized Pre-Tax Income	$-0.14M
Income after Taxes	$4.52M
Income from Continuous Operations	$4.52M
Consolidated Net Income/Loss	$4.52M
Normalized Income after Taxes	$4.52M
EBIT	$-4.25M
EBITDA	$-2.01M
Weighted-Average Shares Outstanding (Basic)	28.91M
Weighted-Average Shares Outstanding (Diluted)	29.55M
Earnings per Share (EPS) (Basic)	$0.16
Earnings per Share (EPS) (Diluted)	$0.15
Balance Sheet Financials
Current Assets	$348.67M
Property, Plant, and Equipment	$74.06M
Long-Term Assets	$196.06M
Total Assets	$544.73M
Current Liabilities	$50.89M
Long-Term Debt	$8.46M
Long-Term Liabilities	$38.46M
Total Liabilities	$89.35M
Common Equity	$455.38M
Tangible Shareholders Equity	$351.25M
Shareholders Equity	$455.38M
Common Shares Outstanding	28.98M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$14.79M
Cash Flow from Investing Activities	$-50.81M
Cash Flow from Financial Activities	$-1.45M
Beginning Cash	$119.71M
End Cash	$82.23M
Increase/Decrease in Cash	$-37.48M
Stock-Based Compensation	$22.39M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.85
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.02
Gross Margin	79.55%
Operating Margin	-4.93%
EBIT Margin	-4.93%
EBITDA Margin	--
Pre-Tax Profit Margin	-0.17%
Profit Margin	5.25%
Free Cash Flow	$0.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	2.11
Receiveable Turnover	1.65
Days Sales in Receivables	54.62
Return on Equity	0.99%
Return on Tangible Equity	1.29%
Return on Assets	0.83%
Return on Investments	0.98%
Book Value Per Share	$15.71
Free Cash Flow per Share	$0.03
Operating Cash Flow per Share	$0.50

Data from Zacks Investment Research, Inc.